Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
November 29, 2022
Patent Application Number
17693029
Date Filed
March 11, 2022
Patent Citations
Patent Primary Examiner
Disclosed herein are alphavirus vectors that include neoantigen-encoding nucleic acid sequences derived from a tumor of a subject. Also disclosed are nucleotides, cells, and methods associated with the vectors including their use as vaccines.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
